Obesities, Volume 4, Issue 4 (December 2024) – 11 articles

Background: The inflammation associated with overweight and obesity seems to alter iron metabolism, but there are few studies evaluating those conditions in children. Thus, we aimed to evaluate the leukometric, immunological, and hematimetric parameters of overweight and obese schoolchildren. Methods: This is a cross-sectional study in which 39 children living in Chonim de Cima (Brazil) underwent anthropometric, hematological, and immunological assessments. The evaluated parameters were compared between the study group (overweight/obesity, n = 15) and the control group (n = 24). Unpaired t-test, Mann–Whitney test, and linear regression were used for statistical tests, and the panoramic profile was used to illustrate differences between groups. Results: The study group had lower mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) and higher TNF levels compared to the control group. Positive correlations were observed between BMI-for-age percentile and total leukocytes (r = 0.1493; p = 0.0151) or neutrophils (r = 0.1395; p = 0.0192). Negative correlations between the BMI-for-age percentile and MCV (r = 0.1464; p = 0.0162) and MCH (r = 0.1460; p = 0.0164) were found. Furthermore, through the panoramic profile, it was noted that the study group had a higher frequency of individuals with high levels of TNF and lower frequencies of individuals with increased hemoglobin and serum iron. Conclusions: Our data suggest that overweight and obesity contribute to a pro-inflammatory context (leukocytes, neutrophils, and TNF) and MCV and MCH reduction in schoolchildren. Full article

The study examines the link between dietary diversity and BMI using data from Kenyan women aged 15–49. By exploring how dietary diversity affects BMI across various BMI categories, the study examines the demand for diet diversity and its impact on BMI. The results reveal a positive relationship between food diversity and BMI at all quantiles, suggesting that a more varied diet is associated with increased BMI levels among underweight, overweight, and obese individuals. This indicates that the correlation between dietary diversity and health outcomes in higher BMI categories may be ‘unfavourable’, with increased food diversity linked to a higher risk of ‘unfavourable’ BMI categories, i.e., overweight and obesity. This may be attributed to higher caloric intake and/or higher consumption of saturated fats and cholesterol from a more diverse diet, which can contribute to increased BMI. These findings highlight the need to consider moderation and balance in energy intake and the overall nutritional quality of diets when considering and evaluating diets and dietary diversity and in formulating and shaping food policies. Full article

Obesity is a multifaceted health issue linked to conditions like type 2 diabetes, hypertension, and cardiovascular disease. Bariatric surgery is a well-established method for significant weight loss and health improvement, but maintaining weight loss and recovering post-surgery can be challenging. Probiotics, beneficial live microorganisms, are suggested as potential aids in managing obesity and its complications, but research on their effectiveness in this context is limited and diverse. This study aimed to evaluate the impact of probiotics on obesity in individuals post-bariatric surgery. A meta-umbrella review was conducted, analyzing systematic reviews and meta-analyses of probiotics’ effects. The review included studies from PubMed, Scopus, EMBASE, and Cochrane Library, focusing on weight loss, body composition, and metabolic parameters. Four systematic reviews met the criteria. The findings indicate that probiotics may significantly reduce waist circumference and body weight, and improve lipid and liver markers. However, their effects on glycemic parameters, quality of life, and adverse events were less clear. Overall, probiotics might offer modest benefits in managing weight and improving certain metabolic parameters after bariatric surgery. However, their overall efficacy, especially regarding glycemic control and quality of life, remains uncertain. Further high-quality research is needed to confirm these findings and elucidate the mechanisms involved. Full article

Sociodemographic factors affect how metabolic syndrome (MetS) manifests and progresses. This study aimed to investigate the prevalence between MetS and sociodemographic factors among adult participants in the Dikgale HDSS. This was a comprehensive retrospective study where the records of 575 participants were meticulously evaluated. MetS was defined using a joint interim statement (JIS). The data were analyzed using the Statistical Package for SPSS, version 25. A chi-square test was used to compare proportions between groups, with Cramer’s V used to assess the strength of association. Logistic regression was used to determine the association between MetS and sociodemographic profiles. A p-value of less than 0.05 was considered statistically significant. The prevalence of MetS was 28.2% (females 33.3% vs. males 15.6%, p ≤ 0.001). In addition, logistic regression showed males to have lower odds of MetS as compared to females (OR = 0.36, 95% CI: 0.2–0.6, and AOR = 0.4, 95% CI: 0.2–0.6). The 55–60 age group had the highest proportion of affected individuals, and MetS was also more common among individuals with low educational attainment. In addition, on regression, the same association was observed. This study found sociodemographic disparities in MetS among rural adults, especially females, who had an increased risk of MetS, and participants with low educational attainment. Full article

(1) Background: The literature has demonstrated several pathways that link obesity with stress. Thus, new approaches to weight management programs must also integrate health coaching and telemonitoring for overall health and wellbeing. This study aimed to measure stress, anxiety, and depression scales (DASS-21) in overweight and obese participants who joined a pilot randomized controlled trial (RCT) and the association between changes in DASS-21 scores and changes in anthropometric measures. (2) Methods: Fifty participants were enrolled in a randomized controlled trial and divided into two groups: the intervention group, which received a hypocaloric diet remotely, weekly telemonitoring, and monthly telehealth coaching, and the control group, which only followed a hypocaloric diet without any support. The Arabic version of the Depression Anxiety Stress Scales (DASS-21) was used. (3) Results: The data reveal that participants from the intervention group exhibited a significant decrease in the anxiety scale after 3 months compared with the control group. In addition, the correlations between depression, anxiety, stress, and all anthropometric measures in the intervention group showed a moderately significant positive correlation between changes in waist circumference and depression. (4) Conclusions: The findings confirm that integrating health coaching and telemonitoring can improve wellbeing and weight loss. Full article

Rapid weight loss strategies and weight cycling (losing and gaining weight repeatedly) are acknowledged problems in sports with weight categories, including judo. Extreme fasting, especially if combined with dehydration and intense physical exercise, may harm health and development, particularly those of children and teenagers engaging in judo competitions. However, there is substantial evidence for positive health effects of other forms of fasting. Here, we aim to provide an updated overview of the potential health risks associated with extreme dietary strategies in judo and contrast them with health-promoting fasting approaches. We conclude that the literature on the long-term health consequences of fasting in judo is scarce. This applies specifically to its potential association with eating disorders. Although many reports have highlighted the short-term risks of rapid weight loss, vulnerability and protection factors remain poorly understood. Rigorous scientific studies are needed to disentangle the factors that render fasting in judo healthy or unhealthy, considering both physical and mental health. We argue that a better understanding of weight management in judo is crucial to preventing health risks and designing healthy weight loss strategies, especially for young athletes. Full article

(1) Background: The administration of subcutaneous (SC) injectables is among the most frequent procedures a nurse performs in daily practice. The needle for the injection must pass through the skin barrier to reach the SC space, where the drug will be deposited. This procedure can cause pain to the patient and local lesions. Local fat measurement can be performed by measuring the skin fold. Previous studies have found higher levels of pain in people with obesity receiving SC insulin, and this study thus aimed to measure pain levels during and after an SC injection of low-molecular-weight heparin (LMWH) and identify how age, gender, and obesity may modulate the level of pain during and after the procedure. (2) Methods: This was a cross-sectional study, and the variables included age, gender, body mass index (BMI), BMI quartile, abdominal skin folds (ASFs), ASF quartile, and pain level during and after injection. A caliper was used to measure ASFs, height and weight were used to calculate BMI, and the Visual Analog Scale (VAS) was used to measure pain. (3) Results: The sample amounted to 202 participants, which was not considered representative of the study population. The average age was 64.3 years, and females predominated (62.40%). Of these participants, 42.5% were obese, and 29.1% were overweight. The average pain levels were low during (1.4) and after injection (1.9), highlighting the absence of pain during injection in 29.7% and after injection in 34.2%. (4) Conclusions: Obesity was associated with increased pain, but when adjusted for age, the pain was no longer significant. Females and young participants showed a significant relationship with pain during injection. Age, gender, and obesity had a statistically significant relationship with pain level. Participants with obesity (according to BMI and ASF) showed the highest levels of pain during and after injection. After injection, there was an increase in pain in most cases, possibly due to the discomfort caused by the drug itself, an aspect considered in the drug’s technical data sheet as a frequent adverse effect (>1/10 to <1/100). However, the drug volume does not seem to be related to pain in this study. Full article

Background: Research suggests that commercial weight management services are efficacious in helping people manage their body mass, but they typically only include education and advice on physical activity. The objective of this analysis was to assess 3- and 12-month body mass after attendance at a community-based weight management programme delivered by a commercial slimming group, which included the provision of tailored physical activity sessions by a local leisure trust between January 2009 and November 2014. Methods: After institutional ethical approval and participants giving informed consent, a retrospective analysis of a 12-week multi-component intervention, tier 2 community weight management service for adults in Wigan, North West England, United Kingdom, was undertaken. Participants’ (n = 8514) mean ± SD age was 47.4 ± 14.3 years and starting body mass was 86.7 ± 14.3 kg. The main outcome measure was body mass (kg) at 0 months (baseline), 3 months (immediately post intervention) and 12 months. Significant differences in body mass were ascertained if p < 0.05 using repeated measures ANOVA with Bonferroni post hoc test, with effect sizes calculated using partial eta squared. To confirm and account for missing data, the Last Observation Carried Forward (LOCF) approach was used. Results: Repeated measures ANOVA showed a significant effect of time (p < 0.01, ${\eta }_p^2$ = 0.36). Post hoc tests revealed there was a significant reduction in body mass from baseline to 3 months (86.7 ± 14.3 kg vs. 81.2 ± 13.6 kg) and baseline to 12 months (79.7 ± 14.0 kg). The difference between 3 months and 12 months was also significant. LOCF confirmed a significant effect of time (p < 0.01, ${\eta }_p^2$ = 0.42), with all previously highlighted significant differences remaining. Conclusions: Significant reductions in body mass were reported at 3 and 12 months, providing evidence for the efficacy of the community weight management programme that included tailored physical activity opportunities for participants. Whilst comparisons to a resting control group cannot be made, partnerships between commercial slimming groups and local leisure providers should be encouraged and explored nationally. Full article

Background: There are still discrepancies in the literature as to whether COVID-19 infection could impact biochemical, anthropometric, and cardiovascular markers. The purpose of this study was firstly to observe the effects of COVID-19 infection over 12 months on Type 2 diabetes (T2D) and obesity. Secondarily, we analyzed the individual influence of COVID-19 infection on changes in biochemical, anthropometric, and cardiovascular markers. Methods: This study is part of a secondary analysis of a recently published article. The research involved 84 participants with T2D, divided into two groups: the control group (40 participants) received only medical care, while the intervention group (44 participants) received both medical care and nutritional assessment. Consultations were held quarterly over 12 months, with a follow-up after 3 months. Data Analysis: For influence analysis, non-normal variables were compared using the Mann–Whitney test, and normal variables were compared using unpaired t-tests. For all cases, α = 0.05 and p < 0.05 were considered significant. Results: The analysis revealed a high percentage of patients in both groups who had a COVID-19 infection (70% control and 72.7% intervention) over 12 months. Regarding the influence analysis, participants in the intervention group who were infected with COVID-19 showed smaller reductions in glycated hemoglobin (HbA1c) (p = 0.0120) and systolic blood pressure (SBP) (p = 0.0460). For the other biochemical, anthropometric, and cardiovascular markers, in both groups, no significant differences were found (p > 0.05). Conclusion: COVID-19 possibly influenced SBP and HbA1c levels over 12 months in people with T2D and obesity. However, caution should be exercised in generalizing these results due to the limitations of this study. Additionally, influence analysis does not establish a causal relationship, and more clinical trials in different populations are needed to fully analyze this topic. Full article

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were originally developed in the late 1980s as a class of antidiabetic medication. However, research over the past decade has found them to be a safe and effective weight-loss agent, which has led to the approval of GLP-1 RAs such as Semaglutide as a supplement to lifestyle obesity interventions in multiple countries. When Semaglutide has become commercially unavailable, digital weight-loss services (DWLSs) have prescribed a compounded form of the medication—a practice in which health professionals formulate a replica of the commercial medication to serve ongoing patient needs. Although compounding has been relatively common over the past century, prominent medical bodies have argued that compounding a relatively novel medication such as Semaglutide represents a major safety risk. This study retrospectively compared the weight and side effect outcomes of patients from a large Australian DWLS whose lifestyle coaching was supplemented with either compounded or pure Semaglutide (both groups following the same titration schedule). All data were extracted from the service’s central data repository. To be included in the weight loss analysis, patients needed to have received a minimum of four monthly medication orders between June 2023 and May 2024 and have submitted weight data between 90 and 150 days after the arrival of their first order. All patients who received at least one medication order within the same period were included in the side effect analysis. The mean four-month weight loss percentage was statistically lower in the compounded Semaglutide group (N = 923, M = 9.11, SD = ±5.76) compared to those in the pure Semaglutide group (n = 1858, M = 9.87, SD = ±6.46), t (2032) = −3.15, p = 0.0017. A statistically lower proportion of patients in the compounded Semaglutide group (71.61%) reported at least one side effect than patients in the pure Semaglutide group (77.40%) during the study period, X² (1, N = 7683) = 32.32, p < 0.001. When side effects were disaggregated into severity categories, a statistical difference was only observed in mild side effects, X² (1, N = 7683) = 59.16, p < 0.001. A significantly higher rate of patients from the pure Semaglutide group achieved the ten (50.54% vs. 44.64%), X² (1, N = 7683) = 10.34, p < 0.001, and fifteen (21.42% vs. 12.78%), X² (1, N = 7683) = 30.43, p < 0.001, percent weight loss thresholds than patients from the compounded Semaglutide group. The findings indicate that compounded Semaglutide can be used as a component of tightly controlled DWLSs with slightly less effectiveness but with slightly lower side effect incidence when compared to pure Semaglutide. Full article

Obesity, a complex social issue with profound health implications, intersects with various facets of society, from cultural norms to economic structures. This paper explores the sociology of obesity through multiple lenses, examining its social construction, the evaluation of societal perceptions, and the stigmatisation of obese individuals. It scrutinises the medicalisation of obesity and its consequences, urging caution in policy interventions and the interpretation of scientific evidence. Furthermore, it advocates for a nuanced approach to obesity prevention, emphasising the importance of public health policies grounded in evidence-based practices and a shared responsibility across diverse sectors. By delving into the intricate interplay between science, society. and culture, this research underscores the legitimate conditions of public health actions in fighting against the development of the obesity epidemic. Full article